glp 1 agonist overdose GLP-1 Treatment Associated with a 39% Lower Risk of Repeat Substance Mapping the effectiveness and risks

Description

What is more, it seems that GLP-1R agonists may be useful as an adjunctive to traditional therapy to treat cognitive impairments observed in the course of depression, especially in women

National Academies Press

For GLP-1 drugs, the risks include: Increased anxiety or panic from unstable blood sugar Triggering or worsening depression Heightened risk of obsessive eating behaviors Potential for self-esteem issues or body image dysmorphia For someone already struggling with mental health, these risks are compounded making proper medical oversight essential

Currently, liraglutide, semaglutide, and tirzepatide are FDA-approved for obesity treatment, while other agents are used off-label

How The Study Was Built The investigators used the TriNetX US Collaborative Network and identified 841,831 eligible adult women with breast cancer across 68 healthcare organizations